Literature DB >> 35979925

CAPRIN1 haploinsufficiency causes a neurodevelopmental disorder with language impairment, ADHD and ASD.

Lisa Pavinato1,2, Andrea Delle Vedove2,3, Diana Carli4,5, Marta Ferrero1,6, Silvia Carestiato1, Jennifer L Howe7, Emanuele Agolini8, Domenico A Coviello9, Ingrid van de Laar10, Ping Yee Billie Au11, Eleonora Di Gregorio12, Alessandra Fabbiani13,14,15, Susanna Croci14,15, Maria Antonietta Mencarelli13, Lucia P Bruno14,15, Alessandra Renieri13,14,15, Danai Veltra16, Christalena Sofocleous16, Laurence Faivre17,18, Benoit Mazel17, Hana Safraou18,19, Anne Sophie Denommé-Pichon18,19, Marjon A van Slegtenhorst10, Noor Giesbertz20, Richard H van Jaarsveld20, Anna Childers21, R Curtis Rogers21, Antonio Novelli8, Silvia De Rubeis22,23,24,25, Joseph D Buxbaum22,23,24,26, Stephen W Scherer27,28, Giovanni Battista Ferrero29, Brunhilde Wirth2,3, Alfredo Brusco1,12.   

Abstract

We describe an autosomal dominant disorder associated with loss-of-function variants in the Cell cycle Associated PRoteIN 1 (CAPRIN1; MIM*601178). CAPRIN1 encodes a ubiquitous protein that regulates the transport and translation of neuronal mRNAs critical for synaptic plasticity, as well as mRNAs encoding proteins important for cell proliferation and migration in multiple cell types. We identified twelve cases with loss-of-function CAPRIN1 variants, and a neurodevelopmental phenotype characterized by language impairment/speech delay (100%), Intellectual Disability (ID; 83%), Attention Deficit Hyperactivity Disorder (ADHD; 82%), and Autism Spectrum Disorder (ASD; 67%). Affected individuals also had respiratory problems (50%), limb/skeletal anomalies (50%), developmental delay (42%) feeding difficulties (33%), seizures (33%) and ophthalmologic problems (33%). In patient-derived lymphoblasts and fibroblasts, we showed a monoallelic expression of the wild-type allele, and a reduction of the transcript and protein compatible with a half dose. To further study pathogenic mechanisms, we generated CAPRIN1+/- human iPSCs (hiPSCs) via CRISPR/Cas9 mutagenesis and differentiated them into neuronal progenitor cells and cortical neurons. CAPRIN1 loss caused reduced neuronal processes, overall disruption of the neuronal organization, and an increased neuronal degeneration. We also observed an alteration of mRNA translation in CAPRIN1+/- neurons, compatible with its suggested function as translational inhibitor. CAPRIN1+/- neurons also showed an impaired calcium signalling and increased oxidative stress, two mechanisms that may directly affect neuronal networks development, maintenance, and function. According to what was previously observed in the mouse model, measurements of activity in CAPRIN1+/- neurons via micro-electrode arrays (MEA) indicated lower spike rates and bursts, with an overall reduced activity. In conclusion, we demonstrate that CAPRIN1 haploinsufficiency causes a novel autosomal dominant neurodevelopmental disorder and identify morphological and functional alterations associated with this disorder in human neuronal models.
© The Author(s) 2022. Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  ADHD; ASD; CAPRIN1; RNG105; neurodevelopment

Year:  2022        PMID: 35979925     DOI: 10.1093/brain/awac278

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   15.255


  1 in total

1.  CAPRIN1P512L causes aberrant protein aggregation and associates with early-onset ataxia.

Authors:  Andrea Delle Vedove; Janani Natarajan; Ginevra Zanni; Matthias Eckenweiler; Anixa Muiños-Bühl; Markus Storbeck; Jordina Guillén Boixet; Sabina Barresi; Simone Pizzi; Irmgard Hölker; Friederike Körber; Titus M Franzmann; Enrico S Bertini; Janbernd Kirschner; Simon Alberti; Marco Tartaglia; Brunhilde Wirth
Journal:  Cell Mol Life Sci       Date:  2022-09-22       Impact factor: 9.207

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.